Aurobindo Pharma has informed that an analyst/ investor call on the Unaudited Financial Results of the Company for the third quarter and nine months period ended 31st December 2020 is scheduled on 11th February 2021 at 08:30 hrs.
The above information is a part of company’s filings submitted to BSE.